Diagnostic work-up of inflammatory bowel disease in children: The role of calprotectin assay

A. Diamanti, F. Panetta, Ms Basso

Research output: Contribution to journalArticle

Abstract

Background: Some reports highlight the potential application of fecal calprotectin as a direct biomarker of intestinal inflammation and, therefore, as support in choosing candidates for endoscopy. The value of 100 mcg/g was recently assumed as the best cutoff for this assay. The purpose of this study was to assess the diagnostic precision of the fecal calprotectin assay, compared to histology, as a stool-screening biomarker for inflammatory bowel disease (IBD) among a group of prospectively identified patients referred for recurrent abdominal pain and altered bowel habits. Methods: Between 1999 and 2007 we prospectively evaluated the calprotectin assay in a cohort of patients with recurrent abdominal pain and altered bowel habits associated or not with other symptoms suggestive of IBD. All patients suspected of IBD, according to Rome and Porto criteria, provided stool specimens for the calprotectin assay and subsequently underwent endoscopic procedures. Results: Compared to histology, the cutoff of 100 m g/g reached a sensitivity and specificity of 100% and 68%, respectively, and a likelihood ratio (LR) of 3.1. The cutoff value of 160 mcg/g, however, in our series produced the best joint estimate of sensitivity and specificity: 100% and 80%, respectively, with an LR of 5. Conclusions: In pediatric patients with recurrent abdominal pain and changes in stool habits, a positive calprotectin assay is closely associated with IBD; its systematic employment, therefore, seems to improve the process of endoscopy referral. This test, simple and inexpensive, could be included in the first noninvasive phase of an IBD diagnostic work-up. (published online ahead of print March 22, 2010. Inflamm Bowel Dis.)

Original languageEnglish
Pages (from-to)416-417
Number of pages2
JournalNutrition in Clinical Practice
Volume25
Issue number4
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Leukocyte L1 Antigen Complex
Inflammatory Bowel Diseases
Abdominal Pain
Habits
Endoscopy
Histology
Biomarkers
Sensitivity and Specificity
Referral and Consultation
Joints
Pediatrics
Inflammation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Diagnostic work-up of inflammatory bowel disease in children : The role of calprotectin assay. / Diamanti, A.; Panetta, F.; Basso, Ms.

In: Nutrition in Clinical Practice, Vol. 25, No. 4, 08.2010, p. 416-417.

Research output: Contribution to journalArticle

@article{29d87d9232db4d8bb62408000654b69d,
title = "Diagnostic work-up of inflammatory bowel disease in children: The role of calprotectin assay",
abstract = "Background: Some reports highlight the potential application of fecal calprotectin as a direct biomarker of intestinal inflammation and, therefore, as support in choosing candidates for endoscopy. The value of 100 mcg/g was recently assumed as the best cutoff for this assay. The purpose of this study was to assess the diagnostic precision of the fecal calprotectin assay, compared to histology, as a stool-screening biomarker for inflammatory bowel disease (IBD) among a group of prospectively identified patients referred for recurrent abdominal pain and altered bowel habits. Methods: Between 1999 and 2007 we prospectively evaluated the calprotectin assay in a cohort of patients with recurrent abdominal pain and altered bowel habits associated or not with other symptoms suggestive of IBD. All patients suspected of IBD, according to Rome and Porto criteria, provided stool specimens for the calprotectin assay and subsequently underwent endoscopic procedures. Results: Compared to histology, the cutoff of 100 m g/g reached a sensitivity and specificity of 100{\%} and 68{\%}, respectively, and a likelihood ratio (LR) of 3.1. The cutoff value of 160 mcg/g, however, in our series produced the best joint estimate of sensitivity and specificity: 100{\%} and 80{\%}, respectively, with an LR of 5. Conclusions: In pediatric patients with recurrent abdominal pain and changes in stool habits, a positive calprotectin assay is closely associated with IBD; its systematic employment, therefore, seems to improve the process of endoscopy referral. This test, simple and inexpensive, could be included in the first noninvasive phase of an IBD diagnostic work-up. (published online ahead of print March 22, 2010. Inflamm Bowel Dis.)",
author = "A. Diamanti and F. Panetta and Ms Basso",
year = "2010",
month = "8",
doi = "10.1177/0884533610374963",
language = "English",
volume = "25",
pages = "416--417",
journal = "Nutrition in Clinical Practice",
issn = "0884-5336",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Diagnostic work-up of inflammatory bowel disease in children

T2 - The role of calprotectin assay

AU - Diamanti, A.

AU - Panetta, F.

AU - Basso, Ms

PY - 2010/8

Y1 - 2010/8

N2 - Background: Some reports highlight the potential application of fecal calprotectin as a direct biomarker of intestinal inflammation and, therefore, as support in choosing candidates for endoscopy. The value of 100 mcg/g was recently assumed as the best cutoff for this assay. The purpose of this study was to assess the diagnostic precision of the fecal calprotectin assay, compared to histology, as a stool-screening biomarker for inflammatory bowel disease (IBD) among a group of prospectively identified patients referred for recurrent abdominal pain and altered bowel habits. Methods: Between 1999 and 2007 we prospectively evaluated the calprotectin assay in a cohort of patients with recurrent abdominal pain and altered bowel habits associated or not with other symptoms suggestive of IBD. All patients suspected of IBD, according to Rome and Porto criteria, provided stool specimens for the calprotectin assay and subsequently underwent endoscopic procedures. Results: Compared to histology, the cutoff of 100 m g/g reached a sensitivity and specificity of 100% and 68%, respectively, and a likelihood ratio (LR) of 3.1. The cutoff value of 160 mcg/g, however, in our series produced the best joint estimate of sensitivity and specificity: 100% and 80%, respectively, with an LR of 5. Conclusions: In pediatric patients with recurrent abdominal pain and changes in stool habits, a positive calprotectin assay is closely associated with IBD; its systematic employment, therefore, seems to improve the process of endoscopy referral. This test, simple and inexpensive, could be included in the first noninvasive phase of an IBD diagnostic work-up. (published online ahead of print March 22, 2010. Inflamm Bowel Dis.)

AB - Background: Some reports highlight the potential application of fecal calprotectin as a direct biomarker of intestinal inflammation and, therefore, as support in choosing candidates for endoscopy. The value of 100 mcg/g was recently assumed as the best cutoff for this assay. The purpose of this study was to assess the diagnostic precision of the fecal calprotectin assay, compared to histology, as a stool-screening biomarker for inflammatory bowel disease (IBD) among a group of prospectively identified patients referred for recurrent abdominal pain and altered bowel habits. Methods: Between 1999 and 2007 we prospectively evaluated the calprotectin assay in a cohort of patients with recurrent abdominal pain and altered bowel habits associated or not with other symptoms suggestive of IBD. All patients suspected of IBD, according to Rome and Porto criteria, provided stool specimens for the calprotectin assay and subsequently underwent endoscopic procedures. Results: Compared to histology, the cutoff of 100 m g/g reached a sensitivity and specificity of 100% and 68%, respectively, and a likelihood ratio (LR) of 3.1. The cutoff value of 160 mcg/g, however, in our series produced the best joint estimate of sensitivity and specificity: 100% and 80%, respectively, with an LR of 5. Conclusions: In pediatric patients with recurrent abdominal pain and changes in stool habits, a positive calprotectin assay is closely associated with IBD; its systematic employment, therefore, seems to improve the process of endoscopy referral. This test, simple and inexpensive, could be included in the first noninvasive phase of an IBD diagnostic work-up. (published online ahead of print March 22, 2010. Inflamm Bowel Dis.)

UR - http://www.scopus.com/inward/record.url?scp=78649307624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649307624&partnerID=8YFLogxK

U2 - 10.1177/0884533610374963

DO - 10.1177/0884533610374963

M3 - Article

AN - SCOPUS:78649307624

VL - 25

SP - 416

EP - 417

JO - Nutrition in Clinical Practice

JF - Nutrition in Clinical Practice

SN - 0884-5336

IS - 4

ER -